VITTI, PAOLO
 Distribuzione geografica
Continente #
NA - Nord America 28.609
EU - Europa 15.336
AS - Asia 3.554
AF - Africa 504
SA - Sud America 63
OC - Oceania 34
Continente sconosciuto - Info sul continente non disponibili 15
Totale 48.115
Nazione #
US - Stati Uniti d'America 25.621
IT - Italia 7.139
CA - Canada 2.964
SE - Svezia 2.453
CN - Cina 1.960
DE - Germania 1.861
BG - Bulgaria 1.167
GB - Regno Unito 698
TR - Turchia 535
UA - Ucraina 433
VN - Vietnam 409
AT - Austria 385
FI - Finlandia 371
CI - Costa d'Avorio 282
FR - Francia 219
SG - Singapore 197
IN - India 163
CH - Svizzera 146
SN - Senegal 144
RU - Federazione Russa 134
HK - Hong Kong 128
BE - Belgio 85
NL - Olanda 51
GR - Grecia 46
NG - Nigeria 37
RO - Romania 28
AU - Australia 27
JP - Giappone 27
PL - Polonia 27
BR - Brasile 26
KR - Corea 23
IE - Irlanda 21
ES - Italia 19
IR - Iran 18
MY - Malesia 16
EG - Egitto 12
EU - Europa 11
ZM - Zambia 11
MX - Messico 10
TW - Taiwan 10
CZ - Repubblica Ceca 9
PY - Paraguay 9
CL - Cile 8
DK - Danimarca 8
JO - Giordania 8
UZ - Uzbekistan 8
NZ - Nuova Zelanda 7
TH - Thailandia 7
CR - Costa Rica 6
HU - Ungheria 6
CO - Colombia 5
EC - Ecuador 5
HR - Croazia 5
ID - Indonesia 5
IL - Israele 5
PH - Filippine 5
ZA - Sudafrica 5
KE - Kenya 4
PK - Pakistan 4
RS - Serbia 4
SA - Arabia Saudita 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AE - Emirati Arabi Uniti 3
AL - Albania 3
AR - Argentina 3
CY - Cipro 3
LY - Libia 3
PE - Perù 3
SK - Slovacchia (Repubblica Slovacca) 3
SM - San Marino 3
BH - Bahrain 2
BY - Bielorussia 2
DZ - Algeria 2
IQ - Iraq 2
IS - Islanda 2
JM - Giamaica 2
KZ - Kazakistan 2
LU - Lussemburgo 2
MT - Malta 2
NO - Norvegia 2
SV - El Salvador 2
UY - Uruguay 2
VE - Venezuela 2
A1 - Anonimo 1
AZ - Azerbaigian 1
BN - Brunei Darussalam 1
BW - Botswana 1
EE - Estonia 1
GE - Georgia 1
GT - Guatemala 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MA - Marocco 1
ME - Montenegro 1
MN - Mongolia 1
MW - Malawi 1
NP - Nepal 1
PA - Panama 1
PR - Porto Rico 1
Totale 48.111
Città #
Woodbridge 3.391
Fairfield 3.261
Ann Arbor 2.468
Houston 2.392
Montreal 2.304
Chandler 2.151
Ashburn 1.818
Seattle 1.356
Milan 1.230
Wilmington 1.198
Sofia 1.164
Cambridge 1.052
Beijing 750
New York 698
Ottawa 619
Princeton 508
Serra 470
Lawrence 447
Izmir 445
Jacksonville 445
Medford 398
Vienna 355
Nanjing 336
Des Moines 327
Rome 326
Abidjan 282
Florence 278
Dearborn 202
Dong Ket 168
Boulder 154
San Diego 152
Pisa 151
Dakar 144
Frankfurt am Main 125
London 125
Falls Church 119
Redwood City 119
Bern 115
Nanchang 115
Bremen 114
Hong Kong 105
Jüchen 99
Lancaster 90
Naples 80
Kunming 78
Brussels 76
Hebei 74
Shenyang 73
Marseille 70
Bologna 65
Tianjin 59
Turin 59
Washington 57
Detroit 56
Jiaxing 56
Changsha 54
Bari 53
Ogden 53
Palermo 53
Hefei 51
Brescia 49
Jinan 48
Düsseldorf 47
Kocaeli 42
Catania 40
Nürnberg 39
Lagos 37
Norwalk 37
Dallas 33
Pune 33
Shanghai 33
Padova 32
Ningbo 31
Phoenix 30
Boardman 29
Hangzhou 29
Chicago 28
Napoli 26
Guangzhou 25
Istanbul 23
Sacile 23
Vicopisano 23
San Francisco 22
Los Angeles 21
Verona 21
Bergamo 20
Lanzhou 20
Torino 20
Indiana 19
Redmond 19
Chengdu 18
Genoa 18
Helsinki 18
Zhengzhou 18
Toronto 17
Auburn Hills 16
Cagliari 16
Livorno 16
Lucca 15
Mumbai 15
Totale 34.699
Nome #
Tiroidite cronica autoimmune 6.843
Ontogenetic development of pancreatic thyrotropin-releasing hormone in human foetuses and in infants. 310
Are the clinical and pathological features of differentiated thyroid carcinoma really changed over the last 35 years? Study on 4187 patients from a single Italian institution to answer this question. 185
Leonardo da Vinci "Design of Lady with Graves' disease" (1452-1519) 175
The presence of a tall cells>10% in a classical variant of papillary thyroid carcinoma (CV-PTC) makes its aggressiveness similar to that of tall cell variant (TCV-PTC) 173
In silico and in vitro analysis of rare germline allelic variants of RET oncogene associated with medullary thyroid cancer 169
Natural history of graves’ orbitopathy after treatment 164
Expression of the microsomal antigen on the surface of continuously cultured rat thyroid cells is modulated by thyrotropin. 161
Sera of patients with idiopathic myxedema contain IgG which block TSH-stimulated thyroid adenylate cyclase 161
null 160
A study on the relationship between intraglandular arterial distribution and thyroid lobe shape: implications for biotechnology of a bioartificial thyroid 158
null 157
Identification of a novel mutation in the polymerase delta 1 (POLD1) gene in a lipodystrophic patient affected by mandibular hypoplasia, deafness, progeroid features (MDPL) syndrome 154
Anaplastic thyroid carcinoma: from clinicopathology to genetics and advanced therapies 154
Effects of bariatric surgery on preclinical myocardial alterations in severe obesity 153
Presence in the pre-surgical fine-needle aspiration of potential thyroid biomarkers previously identified in the post-surgical one. 151
Causes and laboratory investigations of thyrotoxicosis 150
Antioxidant Actions of Selenium in Orbital Fibroblasts: A Basis for the Effects of Selenium in Graves' Orbitopathy 147
Role of the underlying thyroid disease on the phenotype of graves' orbitopathy in a tertiary referral center 146
Role of thyroid ultrasound in the diagnostic evaluation of thyroid nodules 145
V804M RET MUTATION AND VANDETANIB RESPONSE IN METASTATIC MEDULLARY THYROID CANCER 145
In vitro assay of thyroid disruptors affecting TSH-stimulated adenylate cyclase activity 144
Proteomic analysis of fine-needle aspiration in differential diagnosis of thyroid nodules. 144
Could improved ultrasound and power Doppler replace thyroidal radioiodine uptake to assess thyroid disease? 143
Changing Trend of Thyroglobulin Antibodies in Patients with Differentiated Thyroid Cancer Treated with Total Thyroidectomy Without ¹³¹I Ablation 143
Results of Vardenafil Mediated Power Doppler Ultrasound, Contrast Enhanced Ultrasound and Systematic Random Biopsies to Detect Prostate Cancer 142
Thyrotropin stimulation of the ADP-ribosyltransferase activity of bovine thyroid membranes. 141
Radioactive iodine (131I) effects on male fertility 141
Hepatic left lobe volume is a sensitive index of metabolic improvement in obese women after gastric banding 141
Treatment of advanced thyroid cancer with targeted therapies: Ten years of experience 140
Identification of two distinct molecular subtypes by digital RNA counting of "non-invasive follicular tumour with papillary-like nuclear features (NIFTP)" 140
Prevalence of thyroid peroxidase, thyroglobulin and thyrotropin receptor antibodies in a long-term follow-up of juvenile Graves disease 139
Spontaneous improvement of untreated mild graves' ophthalmopathy: Rundle's curve revisited. 139
A ganglioneuroma with features of a thyroid nodule: intense pain on fine needle biopsy as a diagnostic clue 138
Interference of serum thyroglobulin in the radioassay for serum antithyroglobulin antibodies. 137
Recent advances in the understanding of humoral and cellular mechanisms implicated in thyroid autoimmune disorders. 137
Thyroid blood flow evaluation by color-flow Doppler sonography distinguishes Graves' disease from Hashimoto's thyroiditis. 137
null 137
Thyroid-stimulating antibody mimics thyrotropin in its ability to desensitize the adenosine 3',5'-monophosphate response to acute stimulation in continuously cultured rat thyroid cells (FRT-L5). 136
Use of low-dose radioiodine ablation for Graves' orbitopathy: results of a pilot, perspective study in a small series of patients 136
Diagnosis of thyroid dysfunction: present and future. 135
Action of three bioavailable antioxidants in orbital fibroblasts from patients with Graves’ orbitopathy (GO): a new frontier for GO treatment? 135
Agretti P, De Marco G, De Servi M, Marcocci C, Vitti P, Pinchera A, Tonacchera M.: Evidence for protein and mRNA TSHr expression in fibroblasts from patients with thyroid-associated ophthalmopathy (TAO) after adipocytic differentiation 134
Comparison between thyroid stimulating and tsh-binding inhibiting immunoglobulins of Graves' disease. 134
Could improved ultrasound and power Doppler replace thyroidal radioiodine uptake to assess thyroid disease? 133
A patient with MEN1 and end‑stage chronic kidney disease due to Alport syndrome: Decision making on the eligibility of transplantation 133
STUDY OF POTENTIAL INHIBITORS OF THYROID IODIDE UPTAKE BY USING CHO CELLS STABLY EXPRESSING THE HUMAN SODIUM/IODIDE SYMPORTER (hNIS) PROTEIN 132
RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC) 132
Molecular interactions at the cell surface: role of glycoconjugates and membrane lipids in receptor recognition processes. 131
Thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: comparison of different assays and evaluation of causes of discrepancies. 131
Electric and magnetic fields do not modify the biochemical properties of FRTL-5 cells 131
Thyroglobulin Antibodies (TgAb) Titer Spontaneously Decrease Until The Negativization Or Stabilization In Most Of Cases Of Papillary Thyroid Microcarcinoma (mPTC) Treated With Total Thyroidectomy But Not Ablated With 131I 131
Authors’ Response: Haptoglobin and Body Mass Index 131
mRNA and miRNA expression profiling of follicular variant of papillary thyroid carcinoma with and without distant metastases 130
Assessment of nodular goitre 129
Ultrasonographic evaluation of liver volume and the metabolic syndrome in obese women 128
Binding of thyroglobulin (Tg) to the low-density lipoprotein receptor-associated protein (RAP) during the biosynthetic pathway prevents premature Tg interactions with sortilin 128
Hypertension, nausea, anorexia and weight loss were significantly associated with better progression-free survival in patients with radioiodine-Refractory Differentiated Thyroid Carcinoma treated with Lenvatinib 128
Artificial neural networks in the outcome prediction of adjustable gastric banding in obese women. 128
Autoantibodies from patients with autoimmune thyroid disease do not interfere with the activity of the human iodide symporter gene stably transfected in CHO cells. 127
Iodine deficiency from pregnancy to childhood 127
Graves' IgG stimulation of continuously cultured rat thyroid cells: a sensitive and potentially useful clinical assay. 126
Modifications in the Papillary Thyroid Cancer Gene Profile Over the Last 15 Years. 126
Activating thyrotropin receptor mutations are present in nonadenomatous hyperfunctioning nodules of toxic or autonomous multinodular goiter 126
The expression of platelet serotonin transporter (SERT) in human obesity 126
Significance of low levels of thyroglobulin autoantibodies associated with undetectable thyroglobulin after thyroidectomy for differentiated thyroid carcinoma 126
Monoclonal antibodies to the thyrotropin receptor: stimulating and blocking antibodies derived from the lymphocytes of patients with Graves disease. 125
A TSHr-LH/CGr Chimera that Measures Functional TSAb in Graves' Disease. 125
Characterization of the optimal stimulatory effects of graves' monoclonal and serum immunoglobulin G on adenosine 3',5'-monophosphate production in fRTL-5 thyroid cells: a potential clinical assay. 124
null 124
Expression of IP-10/CXCL10 and MIG/CXCL9 in the thyroid and increased levels of IP-10/CXCL10 in the serum of patients with recent-onset Graves' disease 123
Appearance of thyroid stimulating antibody and Graves' disease after radioiodine therapy for toxic nodular goitre. 123
null 121
The spectrum of thyroid disorders in an iodine deficient community: the Pescopagano survey 121
Iodine contributes to thyroid autoimmunity in humans by unmasking a cryptic epitope on thyroglobulin. 121
Percutaneous ethanol injection: what is its role in the management of nodular lesions of endocrine glands? 120
Autoimmune hepatitis during intravenous glucocorticoid pulse therapy for Graves' ophthalmopathy treated successfully with glucocorticoids themselves 120
Real-Time Elastosonography: Useful Tool for Refining the Presurgical Diagnosis in Thyroid Nodules with Indeterminate or Nondiagnostic Cytology 120
Very-low-calorie ketogenic diet (VLCKD) in the management of metabolic diseases: systematic review and consensus statement from the Italian Society of Endocrinology (SIE) 120
Lenvatinib therapy in progressive, radioiodine-refractory, differentiated thyroid carcinoma: analysis of 74 cases followed in a single centre 120
Modifications in the Papillary Thyroid Cancer Gene Profile Over the Last 15 Years. 120
Activating thyrotropin receptor mutations in histologically heterogeneous hyperfunctioning nodules of multinodular goiter. 119
Simultaneous assay of thyroid adenylate cyclase- and growth-stimulating antibodies using FRTL-5 cells. Evidence suggesting their identity in patients with Graves' disease. 118
Thyroid volume in children: role of iodine intake. 118
Lung recurrence of papillary thyroid cancer diagnosed with antithyroglobulin antibodies after 10 years from initial treatment. 118
Non-palpable thyroid nodules in a borderline iodine-sufficient area: detection by ultrasonography and follow-up. 117
Outcome of thyroid function in Graves' patients treated with radioiodine: role of thyroid-stimulating and thyrotropin-blocking antibodies and of radioiodine-induced thyroid damage. 116
HYPERTHYROIDISM AND PREGNANCY. AN ITALIAN THYROID ASSOCIATION (AIT) AND ITALIAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS (AME) JOINT STATEMENT FOR CLINICAL PRACTICE 116
Identification and functional studies of two new dual-oxidase 2 (DUOX2) mutations in a child with congenital hypothyroidism and a eutopic normal-size thyroid gland 116
Interventional bronchoscopy in the treatment of tracheal obstruction secondary to advanced thyroid cancer 116
Successo terapeutico di Lenvatinib in seconda linea in un caso di carcinoma follicolare della tiroide avanzato 116
Interleukin-6: a marker of thyroid-destructive processes? 115
Gozzo diffuso tossico (morbo di Flajani-Basedow-Graves) e tiroidite cronica autoimmune, Inquadramento nosologico e terapia medica 115
Thyroid volume and urinary iodine in European schoolchildren: standardization of values for assessment of iodine deficiency. 114
Thyroid ultrasound as a predicator of thyroid disease. 114
THE LOCATION AND THE REGULATION OF THE TYPE I-IODOTHYRONINE 5'-MONODEIODINASE (TYPE I-MD) IN THE RAT-THYROID - STUDIES USING A SPECIFIC ANTI-TYPE I-MD ANTIBODY 114
Twenty years of lesson learning: How does the RET genetic screening test impact the clinical management of medullary thyroid cancer? 114
null 114
null 114
A TSHR-LH/CGR Chimera that Measures Functional Thyroid-Stimulating Autoantibodies (TSAb) Can Predict Remission or Recurrence in Graves' Patients Undergoing Antithyroid Drug (ATD) Treatment. 113
Totale 20.218
Categoria #
all - tutte 106.233
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 106.233


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20193.459 0 0 0 0 0 0 0 0 0 1.093 1.272 1.094
2019/20209.442 1.065 673 611 656 968 1.031 1.095 772 899 616 843 213
2020/20214.134 417 276 326 208 398 285 243 407 342 383 266 583
2021/20225.807 110 233 135 379 1.190 827 172 260 463 361 238 1.439
2022/20237.855 845 941 577 644 812 911 172 605 1.312 168 638 230
2023/20247.906 729 616 680 434 798 1.001 370 540 240 2.498 0 0
Totale 48.898